Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCHW) Total Current Liabilities (2022 - 2025)

Historic Total Current Liabilities for Envoy Medical (COCHW) over the last 4 years, with Q3 2025 value amounting to $9.0 million.

  • Envoy Medical's Total Current Liabilities fell 94.78% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 94.78%. This contributed to the annual value of $7.5 million for FY2024, which is 347.29% up from last year.
  • As of Q3 2025, Envoy Medical's Total Current Liabilities stood at $9.0 million, which was down 94.78% from $8.0 million recorded in Q2 2025.
  • Envoy Medical's 5-year Total Current Liabilities high stood at $12.7 million for Q3 2023, and its period low was $2.5 million during Q4 2022.
  • Moreover, its 4-year median value for Total Current Liabilities was $7.6 million (2025), whereas its average is $7.5 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first skyrocketed by 18920.21% in 2023, then crashed by 2849.49% in 2024.
  • Envoy Medical's Total Current Liabilities (Quarter) stood at $2.5 million in 2022, then soared by 189.2% to $7.3 million in 2023, then rose by 3.47% to $7.5 million in 2024, then grew by 19.24% to $9.0 million in 2025.
  • Its Total Current Liabilities stands at $9.0 million for Q3 2025, versus $8.0 million for Q2 2025 and $7.6 million for Q1 2025.